Can a new robot-assisted mitral valve surgery program achieve excellence from its earliest cases?
Retrospective analysis presenting a single-center experience with the first 100 cases of a robotic mitral valve program
Valvulopathies
Early aortic valve replacement: is prevention better than cure?
Long-term results of the RECOVERY trial on the management of severe aortic stenosis in asymptomatic patients.
Perceval® prostheses and sex: similar outcomes, but are they truly equivalent? A critical appraisal from the largest published single-center experience
Prospective multicenter registry and meta-regression assessing outcomes after Perceval Plus® implantation according to sex. The findings support comparable early safety in men and women, although several limitations preclude concluding true equivalence.
Trends in aortic valve replacement among patients aged 65 years and younger in the United States
Retrospective observational study based on a nationwide administrative database, aimed at describing contemporary trends in the use of TAVR, surgical bioprosthetic valves, and mechanical valves among patients aged 40 to 65 years undergoing isolated aortic valve replacement in the United States.
TAVR vs isolated SAVR in low-risk patients: 5-year comparative outcomes from the Evolut Low Risk trial
Post hoc subanalysis of the Evolut Low Risk trial comparing 5-year outcomes in 1164 low-risk patients with severe aortic stenosis undergoing isolated aortic valve replacement, either transcatheter (TAVR) or surgical (SAVR).
Beyond TAVI: what the 2025 valvular heart disease guidelines change for cardiac surgeons
A surgeons’ notebook article summarizing the main surgical implications of the 2025 ESC/EACTS guidelines on valvular heart disease and exploring how these recommendations may be translated into daily clinical practice.
A second chance in minimally invasive mitral valve repair?
This study evaluates the safety and short- and mid-term outcomes of performing second aortic cross-clamping (2nd XCL) in patients undergoing minimally invasive mitral valve repair (MI-MVr) when the initial repair does not achieve an acceptable result.
Partner 2 at 10 years: surgery should remain a valid option in intermediate-risk patients
This study analyzes the 10-year clinical and echocardiographic outcomes of the randomized PARTNER 2A trial, which compared transcatheter aortic valve implantation using transfemoral or transthoracic transapical or transaortic access with the SAPIEN XT prosthesis versus surgery in patients with severe symptomatic aortic stenosis and intermediate surgical risk.
Indications, like principles, can be changed if they do not suit us
A critical appraisal of a Spanish first-in-human experience of TAVI valve-in-valve implantation within a previous mechanical prosthesis.
Mechanical versus biological valve in patients aged 50 to 70 years: do we still lack a definitive answer?
This article reviews the systematic review and meta-analysis by Trevis et al. comparing long-term outcomes after aortic valve replacement (AVR) with mechanical versus bioprosthetic valves in patients aged 50 to 70 years.